CAR-T therapies not cost-effective for diffuse large B-cell lymphoma
For patients with diffuse large B-cell lymphoma (DLBCL), the chimeric antigen receptor T-cell therapies (CAR-T) axicabtagene ciloleucel (axi-cel) and lisocabtagene
Read more
For patients with diffuse large B-cell lymphoma (DLBCL), the chimeric antigen receptor T-cell therapies (CAR-T) axicabtagene ciloleucel (axi-cel) and lisocabtagene
Read moreVisual hallucinations are common among people with Lewy body dementia and other types of dementia. Identifying visual hallucinations is an
Read moreThe Fred Hutchinson Cancer Center, an independent organization also serving as the cancer program for the University of Washington School
Read moreAustralian parents face similar barriers to delivering regular and nutritious meals as families did in the 1990s, amid increasing cost
Read moreThe festive season is fast approaching, and if you’re organizing celebrations with family or friends, you might be grappling with
Read moreA new study led by researchers at Peter Mac has found sharing follow-up care between a GP and hospital-based specialists
Read moreReviewed In a momentous landmark for medical research, UK Biobank has today [Thursday 30 November] unveiled incredible new data from
Read moreHow do emergency department staff determine whether older adults who have fallen need imaging? A new decision rule will help
Read moreEXCLUSIVE Experts reveal the chaos that unfolds inside the body when you go just one night without sleep Just one
Read moreLove handles refer to the prominence of skin tissue surrounding your pelvis, just above the hips. While they can be
Read more